Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yee C Lau

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Atrial Fibrillation|December 14, 2016
Management of Atrial Fibrillation in Patients With Kidney DiseaseYee C Lau, Gregory Y H Lip
Chest|November 5, 2014
Atrial fibrillation during sepsis: a determinant of long-term outcomes?Yee C Lau, Gregory Y H Lip
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 29, 2013
Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?Yee C Lau, Gregory Y H Lip
Expert Opinion on Pharmacotherapy|August 13, 2014
New advances in the treatment of atrial fibrillation: focus on stroke preventionYee C Lau, Gregory Y H Lip
Current Opinion in Cardiology|July 17, 2014
Which drug should we use for stroke prevention in atrial fibrillation?Yee C Lau, Gregory Y H Lip
Annals of Internal Medicine|May 21, 2014
ACP Journal Club. Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AFYee C Lau, Gregory Y H Lip
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 3, 2014
Assess bleeding risk with HAS-BLED and assess stroke risk with CHA2DS2-VASc in patients with atrial fibrillationYee C Lau, Gregory Yh Lip, Pilar Gallego
Expert Opinion on Drug Metabolism & Toxicology|March 24, 2015
Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillationQinmei Xiong, Yee C Lau, Gregory Y H Lip
Journal of Comparative Effectiveness Research|August 15, 2015
Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillationQinmei Xiong, Yee C Lau, Gregory Y H Lip
The American Journal of Cardiology|February 18, 2014
Atrial fibrillation and heart failure: a bad combinationYee C Lau, Deirdre A Lane, Gregory Y H Lip
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Atrial Fibrillation|December 14, 2016
Management of Atrial Fibrillation in Patients With Kidney DiseaseYee C Lau, Gregory Y H Lip
Chest|November 5, 2014
Atrial fibrillation during sepsis: a determinant of long-term outcomes?Yee C Lau, Gregory Y H Lip
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 29, 2013
Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?Yee C Lau, Gregory Y H Lip
Expert Opinion on Pharmacotherapy|August 13, 2014
New advances in the treatment of atrial fibrillation: focus on stroke preventionYee C Lau, Gregory Y H Lip
Current Opinion in Cardiology|July 17, 2014
Which drug should we use for stroke prevention in atrial fibrillation?Yee C Lau, Gregory Y H Lip
Annals of Internal Medicine|May 21, 2014
ACP Journal Club. Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AFYee C Lau, Gregory Y H Lip
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 3, 2014
Assess bleeding risk with HAS-BLED and assess stroke risk with CHA2DS2-VASc in patients with atrial fibrillationYee C Lau, Gregory Yh Lip, Pilar Gallego
Expert Opinion on Drug Metabolism & Toxicology|March 24, 2015
Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillationQinmei Xiong, Yee C Lau, Gregory Y H Lip
Journal of Comparative Effectiveness Research|August 15, 2015
Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillationQinmei Xiong, Yee C Lau, Gregory Y H Lip
The American Journal of Cardiology|February 18, 2014
Atrial fibrillation and heart failure: a bad combinationYee C Lau, Deirdre A Lane, Gregory Y H Lip
Pageof 2